Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.31	90.84	94.93
Graham Fair Price	22.57	15.46	12.62
PEG	2.42	3.32	3.24
Price/Book	-1.61	1.92	1.95
Price/Cash Flow	-4.71	195.20	204.84
Prices/Earnings	-29.59	103.83	147.46
Price/Sales	0.38	28.41	28.30
Price/FCF	-4.71	195.20	204.84
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-29.52	0.21	-0.30
Operating Margin	-42.87	0.19	-0.33
ROA	49.68	< 0.005	< 0.005
ROE	< 0.005	< 0.005	39.73
ROIC	-0.01	< 0.005	-45.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	< 0.005	-1811.25
Dividends QOQ	< 0.005	< 0.005	-50.51
EBIT QOQ	-5.26	1.61	-69.46
EPS QOQ	0.45	0.31	-31.25
FCF QOQ	-0.43	0.12	-72.28
Revenue QOQ	0.05	0.06	20.63
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	22.84	24.31	6.42
Inventory Turnover	0.00	1461748000.00	100.00
Debt/Capitalization	0.38	0.34	-11.14
Quick Ratio	2.29	2.10	-8.34
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.28	47.99	3.69
Cash	3.78	4.32	14.14
Capex	-0.33	-0.23	30.99
Free Cash Flow	0.44	0.47	7.06
Revenue	3.19	3.24	1.63
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.45	3.83	-13.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.98	16.94	-19.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating